NIR‐II Light‐Activated Nanoplatform for Synergistic Photothermal and H 2 S‐Mediated Thrombolysis
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202505802 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Lei Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery of the First Affiliated Hospital and Institute for Cardiovascular Science, Suzhou Medical College, Soochow Unive…. Hauptthemen laut MEDLINE: Hydrogen Sulfide, Infrared Rays, Thrombolytic Therapy, Thrombosis. Die Arbeit nennt 51 Literaturangaben. Gefördert von: NSFC, Shenzhen Science and Technology Program, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Occlusive thrombi within blood vessels are a primary cause of life‐threatening cardiovascular diseases, which continue to pose significant global health challenges. Here, we report a polymer nanoplatform that integrates near‐infrared II (NIR‐II) light‐triggered photothermal thrombolysis with intrinsic antithrombotic functionality. A novel semiconducting polymer, featuring intense NIR‐II absorption and exceptionally high photothermal conversion, is rationally engineered to enable rapid and localized light‐to‐heat thrombolysis. A thermosensitive hydrogen sulfide (H 2 S) donor is also incorporated, generating multifunctional “nanosweepers” that combine synergistic photothermal and gas‐mediated thrombolytic activity. The formulation is further functionalized with bis‐serotonin groups, which confer myeloperoxidase‐ and hydrogen peroxide‐responsive thrombus‐targeting capability, ensuring selective accumulation and site‐specific therapy. This agent possesses robust NIR‐II absorption, high photothermal conversion efficiency (77.2%), and pronounced thrombus‐specific enrichment. Importantly, the combination of localized photothermal heating and on‐demand H 2 S release enable rapid, near‐complete thrombolysis in both carotid and lower‐limb arterial thrombosis models, achieving almost full restoration of blood flow. This work establishes a versatile and highly efficient strategy that integrates precise NIR‐II photothermal conversion with H 2 S‐mediated redox regulation, providing a promising platform for site‐specific multimodal synergistic treatment of life‐threatening thrombotic disorders. The findings offer new insights into the design of multifunctional, precision therapeutics for vascular disease management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery of the First Affiliated Hospital and Institute for Cardiovascular Science, Suzhou Medical College, Soochow University, Suzhou, China.
- State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, and Academy for Advanced Interdisciplinary Studies, Nankai University, Tianjin,…
- Nankai International Advanced Research Institute (Shenzhen Futian), Shenzhen, China.
ORCID-Profile: Ji Qi
Förderung
- NSFC
- Shenzhen Science and Technology Program
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Shenzhen Science and Technology Innovation Program
Zitieren
APA
Chen, L., Song, J., Shen, Z., & Qi, J. (2026). NIR‐II Light‐Activated Nanoplatform for Synergistic Photothermal and H 2 S‐Mediated Thrombolysis. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202505802
Vancouver
Chen L, Song J, Shen Z, Qi J. NIR‐II Light‐Activated Nanoplatform for Synergistic Photothermal and H 2 S‐Mediated Thrombolysis. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202505802
BibTeX
@article{Chen2026,
author = {Chen, Lei and Song, Jianwen and Shen, Zhenya and Qi, Ji},
title = {NIR‐II Light‐Activated Nanoplatform for Synergistic Photothermal and H 2 S‐Mediated Thrombolysis},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202505802}
}
EUVIMED